Healthcare entity
All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention APOE4 gene, the most common co-covered peer. The tracked stories average 2 original sources each. JAMA appears in 1 tracked Healthcare story from July 25, 2026.
Last mentioned: Jul 25, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention APOE4 gene, the most common co-covered peer. The tracked stories average 2 original sources each. JAMA appears in 1 tracked Healthcare story from July 25, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering JAMA. Shared-story counts are live from our verified record — not editorial picks.
A new study shows that a p-tau217 blood test can forecast up to 78% ten-year risk of cognitive decline in healthy older adults, raising urgent questions for healthcare providers, payers, and health IT systems about whether and how to implement predictive testing absent disease-modifying treatments.
JAMA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
